The Purple Sky Store
Women's Relaxed T-Shirt
Women's Relaxed T-Shirt
Couldn't load pickup availability
Beyond being a wardrobe staple, this tee also supports an important cause. 40% of all revenue from the Graceful Support Tee goes to Sky Foundation, a non-profit that funds pancreatic cancer research, allowing you to make a positive impact with every wear.
- Soft, lightweight fabric (4.2 oz/y² or 142 g/m²) for all-day comfort
- 100% combed and ring-spun cotton (heather options vary)
- Relaxed fit with pre-shrunk fabric to maintain shape
- Side-seamed construction for a flattering silhouette
- Classic crew neck
Note: Wear this tee with pride, knowing you’re supporting pancreatic cancer research and making a difference.
Share






















Recent News
View all-
Phase 1/2 Trial Launches for Innovative Pancrea...
UCSF researchers begin testing novel TCR-T cell therapy targeting KRAS mutations in advanced pancreatic cancer. A new clinical trial at UCSF has opened to test a first-of-its-kind immunotherapy for advanced...
Phase 1/2 Trial Launches for Innovative Pancrea...
UCSF researchers begin testing novel TCR-T cell therapy targeting KRAS mutations in advanced pancreatic cancer. A new clinical trial at UCSF has opened to test a first-of-its-kind immunotherapy for advanced...
-
FDA Approves NALIRIFOX as First-Line Treatment ...
New frontline treatment offers hope with improved survival outcomes for advanced PDAC patients The U.S. Food and Drug Administration (FDA) has officially approved NALIRIFOX, a new frontline therapy for patients with metastatic...
FDA Approves NALIRIFOX as First-Line Treatment ...
New frontline treatment offers hope with improved survival outcomes for advanced PDAC patients The U.S. Food and Drug Administration (FDA) has officially approved NALIRIFOX, a new frontline therapy for patients with metastatic...
-
Immunotherapy for Pancreatic Ductal Adenocarcin...
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with a 5-year survival rate under 10%. Standard treatments like surgery and chemotherapy often fail because the cancer usually comes...
Immunotherapy for Pancreatic Ductal Adenocarcin...
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with a 5-year survival rate under 10%. Standard treatments like surgery and chemotherapy often fail because the cancer usually comes...